New Fat-Targeting drug tested in healthy volunteers
NCT ID NCT05234736
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a single injection of CBL-514 in 10 healthy volunteers to see how the body processes it and whether it is safe. Researchers measured drug levels in the blood and monitored for side effects. The goal was to gather basic safety and drug behavior information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CBL-514 injection
- What this could lead to
- If successful, this study will help determine the right dose and safety of CBL-514 for future trials targeting fat reduction.
- What could go wrong
- This is a small, early-phase study in healthy people, not patients. It only looks at drug levels and safety, not effectiveness for any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBCUTANEOUS FAT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DermResearch Inc
Austin, Texas, 78759, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.